Safety and efficacy of uninterrupted treatment with edoxaban or warfarin during the peri‐procedural period of catheter ablation for atrial fibrillation

BACKGROUND: The real‐world safety and efficacy of uninterrupted anticoagulation treatment with edoxaban (EDX) or warfarin (WFR) during the peri‐procedural period of catheter ablation (CA) for atrial fibrillation (AF) are yet to be investigated. METHODS: We conducted a two‐center experience, observat...

Descripción completa

Detalles Bibliográficos
Autores principales: Naito, Kazuya, Nakano, Masataka, Iwasa, Atsushi, Maeno, Yoshio, Shintani, Yoshiaki, Yamakawa, Takeshi, Miyashita, Kotaro, Oyama, Keishiro, Nakai, Daisuke, Katagiri, Masaya, Kido, Hideaki, Masuda, Shinichiro, Kohashi, Keiichi, Kawamata, Tetsuya, Tanimoto, Shuzou, Masuda, Naoki, Ogata, Nobuhiko, Isshiki, Takaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411202/
https://www.ncbi.nlm.nih.gov/pubmed/32782633
http://dx.doi.org/10.1002/joa3.12351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411202/
https://www.ncbi.nlm.nih.gov/pubmed/32782633
http://dx.doi.org/10.1002/joa3.12351

Ejemplares similares